Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal antithrombotic strategy in acute coronary syndrome with atrial fibrillation
2019-004805-28Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin in acute coronary syndrome (ACS) and Atrial fibrillation (AFib) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary efficacy composite endpoint. Started Mar 2020; status: completed.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2019-004805-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004805-28.